Feasibility and acceptance of a cloud-based mobile app for antimicrobial stewardship and infection control in Colombian hospitals.

Autor:	Ketcherside WJ; ILÚM Health Solutions, LLC; Kenilworth, NJ, USA., Olson JBF; ILÚM Health Solutions, LLC; Kenilworth, NJ, USA., Hunt LN; ILÚM Health Solutions, LLC; Kenilworth, NJ, USA., Mehta JM; ILÚM Health Solutions, LLC; Kenilworth, NJ, USA., Gutiérrez CP; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria - RAEH, Universidad El Bosque, Bogotá, Colombia.; Centro Médico Imbanaco; Cali, Colombia., Coy LM; Clínica San Francisco; Tuluá, Colombia., Pradera IP; DIME Clínica Neurocardiovascular; Clinic; Cali Colombia., Rivera AD; Centro Médico Imbanaco; Cali, Colombia., Cano JA; OpGen Colombia S.A.S.; Cali, Colombia., Saeed A; OpGen, Inc.; Gaithersburg, MD, USA., Sapiro V; OpGen, Inc.; Gaithersburg, MD, USA., Park BJ; Centers for Disease Control and Prevention; Atlanta, GA, USA., Malpiedi P; Centers for Disease Control and Prevention; Atlanta, GA, USA., Botero MVV; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria - RAEH, Universidad El Bosque, Bogotá, Colombia.
Jazyk:	angličtina
Zdroj:	International journal of infection control [Int J Infect Control] 2020 Jul 23; Vol. 16 (3), pp. 1-6.
DOI:	10.3396/ijic.v16i3.021.20
Abstrakt:	Infection control and antimicrobial stewardship programs (ICASPs) are essential to reduce the emergence and spread of antimicrobial resistance. The primary objective of this study was to assess the feasibility of extending a commercial off-the-shelf (COTS) software for ICASPs in low- and middle-income countries (LMICs). This project involved three hospitals in Colombia, including Centro Médico Imbanaco, Clínica San Francisco, and DIME Clínica Neurocardiovascular. A COTS platform (ILÚM Health Solutions ™ Kenilworth, NJ) was extended to function in a range of technology settings, and translatable to almost any language. ICASP features were added, including clinical practice guidelines, hand hygiene (HH) documentation, and isolation precaution (IP) documentation. The platform was delivered as a smartphone mobile application ("app") for both iOS and Android. The app was successfully implemented at all sites, however, full back-end data integration was not feasible at any site. In contrast to the United States, a suite of surveillance tools and physician-focused decision support without patient data proved to be valuable. Language translation processing occurred quickly and incurred minimal costs. HH and IP compliance tracking were the most used features among ICASP staff; treatment guidelines were most often used by physicians. Use of the app streamlined activities and reduced the time spent on ICASP tasks. Users consistently reported positive impressions including simplicity of design, ease of navigation, and improved efficiency. This ICASP app was feasible in limited-resource settings, highly acceptable to users, and represents an innovative approach to antimicrobial resistance prevention. Competing Interests: Conflicts of Interest WJS, JBFO, LNH and JMM are all employed by ILÚM Health Solutions, LLC, the developer of the mobile application. No conflicts of interest are reported by other authors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu